International Clinical Trial: Dysbiosis-driven metabolic reprogramming and its impact on hypoxic pulmonary hypertension vascular remodeling

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119434) titled 'Dysbiosis-driven metabolic reprogramming and its impact on hypoxic pulmonary hypertension vascular remodeling' on Feb. 27.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: Gansu Provincial People's Hospital

Condition: Hypoxic Pulmonary Arterial Hypertension

Intervention: Copd complicated with hypoxic pulmonary hypertension group:None COPD group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-05

Target Sample Size: Copd complicated with hypoxic pulmonary hypertension group:17;COPD group:17;Healthy Control Group:17;

Countries of Rec...